There is lots of interesting work and studies going on in India at the present, using low potency homeopathy in the treatment of cancer. This one caught my eye as it referred to pancreatic cancer and an outcome of 38.64% 5 year survival of stage 111 and 1V patients which is considerably better than the 6% present outcome across all stages with standard medication. Also all the trial patients have had no chemo or radiotherapy, but were biopsied to confirm diagnosis. So there is good evidence out there for alternative approaches
I will periodically reference as many as I can, and can report good outcomes using a blend from a similar trial done for gliomas that I have used. I will publish the link when I can find it!!
Below is the abstract from the paper followed by a link to access the full paper below it.
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 724743, 7 pages
Psorinum Therapy in Treating Stomach, Gall Bladder, Pancreatic, and Liver Cancers: A Prospective Clinical Study
Aradeep Chatterjee,1 Jaydip Biswas,2 Ashim Chatterjee,1 Sudin Bhattacharya,2Bishnu Mukhopadhyay,3 and Syamsundar Mandal2
1Critical Cancer Management Research Centre & Clinic, 381 S K Deb Road, West Bengal, Kolkata 700 048, India
2Chittaranjan National Cancer Institute, Kolkata 700 026, India
3National Institute of Technology, Durgapur 713209, India
Received 27 November 2009; Revised 14 October 2010; Accepted 27 October 2010
Copyright © 2011 Aradeep Chatterjee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
We prospectively studied the clinical efficacy of an alternative cancer treatment “Psorinum Therapy” in treating stomach, gall bladder, pancreatic and liver cancers. Our study was observational, open level and single arm. The participants’ eligibility criteria included histopathology/cytopathology confirmation of malignancy, inoperable tumor, and no prior chemotherapy or radiation therapy. The primary outcome measures of the study were (i) to assess the radiological tumor response (ii) to find out how many participants survived at least 1 year, 2 years, 3 years, 4 years and finally 5 years after the beginning of the study considering each type of cancer. Psorinum-6x was administered orally to all the participants up to 0.02 ml/Kg body weight as a single dose in empty stomach per day for 2 years along with allopathic and homeopathic supportive cares. 158 participants (42 of stomach, 40 of gall bladder, 44 of pancreatic, 32 of liver) were included in the final analysis of the study. Complete tumor response occurred in 28 (17.72%) cases and partial tumor response occurred in 56 (35.44%) cases. Double-blind randomized controlled clinical trial should be conducted for further scientific exploration of this alternative cancer treatment.